Applied Therapeutics Inc (APLT)
Aktien-Chart
Earnings
Value bought
Letzte 90 Tage
Value sold
Letzte 90 Tage
Net insiders buying
Letzte 90 Tage
Trades (buy and sell)
Letzte 90 Tage
| Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion | Insider und/oder position |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Wert | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 2025-03-04 | V Verkauf |
Chief Medical Officer Führungsperson |
10.366
-1.2%
0,444.561 USD |
10.366 -1.2% | 0,44 | 4.561 USD | |
| 2025-03-06 | 2025-03-04 | V Verkauf |
See Remarks Führungsperson |
447
-0.2%
0,44197 USD |
447 -0.2% | 0,44 | 197 USD | |
| 2025-03-06 | 2025-03-04 | V Verkauf |
See Remarks Geschäftsführender Verwaltungsratsmitglied |
14.502
-3.6%
0,446.381 USD |
14.502 -3.6% | 0,44 | 6.381 USD | |
| 2025-02-07 | 2025-02-06 | V Verkauf |
Chief Medical Officer Führungsperson |
86.078
-8.7%
0,6152.508 USD |
86.078 -8.7% | 0,61 | 52.508 USD | |
| 2025-02-07 | 2025-02-06 | V Verkauf |
See Remarks Führungsperson |
28.117
-9.4%
0,6117.151 USD |
28.117 -9.4% | 0,61 | 17.151 USD | |
| 2025-02-07 | 2025-02-06 | V Verkauf |
See Remarks Geschäftsführender Verwaltungsratsmitglied |
22.950
-5.4%
0,6114.000 USD |
22.950 -5.4% | 0,61 | 14.000 USD | |
| 2024-08-23 | 2024-08-22 | V Verkauf |
Chief Medical Officer Führungsperson |
22.681
-2.2%
5,83132.230 USD |
22.681 -2.2% | 5,83 | 132.230 USD | |
| 2024-08-23 | 2024-08-22 | V Verkauf |
Chief Financial Officer Geschäftsführender Verwaltungsratsmitglied |
13.530
-4.6%
5,8378.880 USD |
13.530 -4.6% | 5,83 | 78.880 USD | |
| 2024-08-14 | 2024-08-14 | V Verkauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied |
119.591
-2.5%
5,93709.175 USD |
119.591 -2.5% | 5,93 | 709.175 USD | |
| 2024-08-14 | 2024-08-13 | V Verkauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied |
357.423
-6.9%
6,182.208.874 USD |
357.423 -6.9% | 6,18 | 2.208.874 USD | |
| 2024-08-14 | 2024-08-12 | V Verkauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied |
300.000
-5.5%
5,981.794.000 USD |
300.000 -5.5% | 5,98 | 1.794.000 USD | |
| 2024-06-10 | 2024-06-06 | V Verkauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
61.795
-1.6%
4,32266.954 USD |
61.795 -1.6% | 4,32 | 266.954 USD | |
| 2024-06-10 | 2024-06-06 | V Verkauf |
Chief Financial Officer Geschäftsführender Verwaltungsratsmitglied |
16.980
-5.5%
4,3273.354 USD |
16.980 -5.5% | 4,32 | 73.354 USD | |
| 2024-06-10 | 2024-06-06 | V Verkauf |
Chief Medical Officer Führungsperson |
22.003
-2.1%
4,3295.053 USD |
22.003 -2.1% | 4,32 | 95.053 USD | |
| 2024-06-06 | 2024-06-05 | V Verkauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
150.000
-2.5%
4,24636.000 USD |
150.000 -2.5% | 4,24 | 636.000 USD | |
| 2024-06-06 | 2024-06-04 | V Verkauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
150.000
-2.4%
4,21631.500 USD |
150.000 -2.4% | 4,21 | 631.500 USD | |
| 2024-03-18 | 2024-03-14 | V Verkauf |
Chief Commercial Officer Führungsperson |
48.871
-6.3%
5,39263.415 USD |
48.871 -6.3% | 5,39 | 263.415 USD | |
| 2024-03-18 | 2024-03-14 | V Verkauf |
Chief Medical Officer Führungsperson |
110.804
-9.7%
5,39597.234 USD |
110.804 -9.7% | 5,39 | 597.234 USD | |
| 2024-03-18 | 2024-03-14 | V Verkauf |
Chief Financial Officer Geschäftsführender Verwaltungsratsmitglied |
28.727
-8.5%
5,39154.839 USD |
28.727 -8.5% | 5,39 | 154.839 USD | |
| 2024-03-18 | 2024-03-14 | V Verkauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
318.573
-7.7%
5,391.717.108 USD |
318.573 -7.7% | 5,39 | 1.717.108 USD | |
| 2023-12-05 | 2023-12-01 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
30.000
+90.9%
2,1865.367 USD |
30.000 +90.9% | 2,18 | 65.367 USD | |
| 2023-12-01 | 2023-11-30 | V Verkauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
3.968
-0.2%
1,977.817 USD |
3.968 -0.2% | 1,97 | 7.817 USD | |
| 2023-12-01 | 2023-11-30 | V Verkauf |
Chief Commercial Officer Führungsperson |
965
-0.3%
1,971.901 USD |
965 -0.3% | 1,97 | 1.901 USD | |
| 2023-12-01 | 2023-11-30 | V Verkauf |
Chief Medical Officer Führungsperson |
1.583
-0.2%
1,973.119 USD |
1.583 -0.2% | 1,97 | 3.119 USD | |
| 2023-11-06 | 2023-11-03 | V Verkauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
143.450
-2.5%
2,31331.370 USD |
143.450 -2.5% | 2,31 | 331.370 USD | |
| 2023-11-06 | 2023-11-02 | V Verkauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
103.808
-1.8%
2,32240.835 USD |
103.808 -1.8% | 2,32 | 240.835 USD | |
| 2023-11-02 | 2023-11-01 | V Verkauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
172.742
-2.9%
2,36407.671 USD |
172.742 -2.9% | 2,36 | 407.671 USD | |
| 2023-11-02 | 2023-10-31 | V Verkauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
155.000
-2.5%
2,41373.550 USD |
155.000 -2.5% | 2,41 | 373.550 USD | |
| 2023-09-29 | 2023-09-27 | V Verkauf |
Chief Commercial Officer Führungsperson |
9.720
-2.5%
2,7026.244 USD |
9.720 -2.5% | 2,70 | 26.244 USD | |
| 2023-09-29 | 2023-09-27 | V Verkauf |
Chief Medical Officer Führungsperson |
10.932
-1.6%
2,7029.516 USD |
10.932 -1.6% | 2,70 | 29.516 USD | |
| 2023-09-29 | 2023-09-27 | V Verkauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
115.632
-4.3%
2,70312.206 USD |
115.632 -4.3% | 2,70 | 312.206 USD | |
| 2023-01-13 | 2023-01-11 | V Verkauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
15.870
-2.1%
0,9114.442 USD |
15.870 -2.1% | 0,91 | 14.442 USD | |
| 2023-01-13 | 2023-01-11 | V Verkauf |
Chief Medical Officer Führungsperson |
6.053
-3.8%
0,915.508 USD |
6.053 -3.8% | 0,91 | 5.508 USD | |
| 2023-01-13 | 2023-01-11 | V Verkauf |
Chief Commercial Officer Führungsperson |
4.495
-4.6%
0,914.090 USD |
4.495 -4.6% | 0,91 | 4.090 USD | |
| 2022-10-14 | 2022-10-14 | K Kauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
50.000
+7.0%
0,6532.250 USD |
50.000 +7.0% | 0,65 | 32.250 USD | |
| 2022-10-13 | 2022-10-13 | K Kauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
73.256
+11.4%
0,5640.891 USD |
73.256 +11.4% | 0,56 | 40.891 USD | |
| 2022-10-12 | 2022-10-12 | K Kauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
38.153
+6.3%
0,5219.943 USD |
38.153 +6.3% | 0,52 | 19.943 USD | |
| 2022-06-29 | 2022-06-27 | K Kauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
2.065.000
+82.9%
1,002.065.000 USD |
2.065.000 +82.9% | 1,00 | 2.065.000 USD | |
| 2022-06-29 | 2022-06-27 | K Kauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
1.435.000
+152.0%
1,001.435.000 USD |
1.435.000 +152.0% | 1,00 | 1.435.000 USD | |
| 2022-05-18 | 2022-05-16 | V Verkauf |
See Remarks Führungsperson |
905
-8.5%
1,651.493 USD |
905 -8.5% | 1,65 | 1.493 USD | |
| 2022-03-23 | 2022-03-23 | K Kauf |
Chief Medical Officer Führungsperson |
30.000
+22.9%
1,9759.100 USD |
30.000 +22.9% | 1,97 | 59.100 USD | |
| 2022-03-23 | 2022-03-22 | K Kauf |
Chief Medical Officer Führungsperson |
21.961
+20.2%
1,9843.483 USD |
21.961 +20.2% | 1,98 | 43.483 USD | |
| 2022-03-23 | 2022-03-21 | K Kauf |
Chief Medical Officer Führungsperson |
12.548
+13.0%
1,8523.214 USD |
12.548 +13.0% | 1,85 | 23.214 USD | |
| 2021-09-14 | 2021-09-14 | K Kauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
9.300
+2.6%
14,49134.740 USD |
9.300 +2.6% | 14,49 | 134.740 USD | |
| 2021-09-14 | 2021-09-13 | K Kauf |
President and CEO Geschäftsführender Verwaltungsratsmitglied Large shareholder |
701
+0.2%
14,6910.298 USD |
701 +0.2% | 14,69 | 10.298 USD | |
| 2021-06-10 | 2021-06-08 | V Verkauf |
Chief Financial Officer Führungsperson |
5.047
-5.4%
21,42108.107 USD |
5.047 -5.4% | 21,42 | 108.107 USD | |
| 2021-06-07 | 2021-06-07 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
260
-100.0%
21,385.559 USD |
260 -100.0% | 21,38 | 5.559 USD | |
| 2021-06-07 | 2021-06-07 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
200
-43.5%
20,434.086 USD |
200 -43.5% | 20,43 | 4.086 USD | |
| 2021-06-07 | 2021-06-04 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
460
-100.0%
19,659.039 USD |
460 -100.0% | 19,65 | 9.039 USD | |
| 2021-06-07 | 2021-06-03 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
460
-100.0%
19,669.044 USD |
460 -100.0% | 19,66 | 9.044 USD | |
| 2021-05-28 | 2021-05-26 | V Verkauf |
Chief Commercial Officer Führungsperson |
2.894
-7.9%
18,3553.105 USD |
2.894 -7.9% | 18,35 | 53.105 USD | |
| 2021-04-30 | 2021-04-30 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
460
-100.0%
18,328.427 USD |
460 -100.0% | 18,32 | 8.427 USD | |
| 2021-04-30 | 2021-04-29 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
460
-100.0%
18,288.409 USD |
460 -100.0% | 18,28 | 8.409 USD | |
| 2021-04-30 | 2021-04-28 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
300
-100.0%
18,925.676 USD |
300 -100.0% | 18,92 | 5.676 USD | |
| 2021-04-30 | 2021-04-28 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
1.340
-81.7%
18,3324.562 USD |
1.340 -81.7% | 18,33 | 24.562 USD | |
| 2021-03-30 | 2021-03-30 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
460
-100.0%
18,438.478 USD |
460 -100.0% | 18,43 | 8.478 USD | |
| 2021-03-30 | 2021-03-29 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
465
-100.0%
18,538.616 USD |
465 -100.0% | 18,53 | 8.616 USD | |
| 2021-03-30 | 2021-03-26 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
465
-100.0%
19,689.151 USD |
465 -100.0% | 19,68 | 9.151 USD | |
| 2021-03-15 | 2021-03-15 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
465
-100.0%
19,619.119 USD |
465 -100.0% | 19,61 | 9.119 USD | |
| 2021-03-15 | 2021-03-12 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
465
-100.0%
19,389.012 USD |
465 -100.0% | 19,38 | 9.012 USD | |
| 2021-03-15 | 2021-03-11 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
465
-100.0%
18,488.593 USD |
465 -100.0% | 18,48 | 8.593 USD | |
| 2021-02-25 | 2021-02-25 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
1.295
-100.0%
23,2030.044 USD |
1.295 -100.0% | 23,20 | 30.044 USD | |
| 2021-02-25 | 2021-02-24 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
600
-100.0%
24,5714.742 USD |
600 -100.0% | 24,57 | 14.742 USD | |
| 2021-02-25 | 2021-02-24 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
1.525
-71.8%
23,7136.158 USD |
1.525 -71.8% | 23,71 | 36.158 USD | |
| 2021-02-25 | 2021-02-23 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
465
-100.0%
21,8410.156 USD |
465 -100.0% | 21,84 | 10.156 USD | |
| 2021-02-24 | 2021-02-19 | K Kauf | Nicht geschäftsführender Verwaltungsratsmitglied |
6.500
+100.0%
22,86148.590 USD |
6.500 +100.0% | 22,86 | 148.590 USD | |
| 2021-02-19 | 2021-02-17 | K Kauf |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
43.478
+3.5%
23,00999.994 USD |
43.478 +3.5% | 23,00 | 999.994 USD | |
| 2021-02-03 | 2021-02-03 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
600
-100.0%
27,3016.380 USD |
600 -100.0% | 27,30 | 16.380 USD | |
| 2021-02-03 | 2021-02-03 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
695
-53.7%
26,3518.313 USD |
695 -53.7% | 26,35 | 18.313 USD | |
| 2021-02-03 | 2021-02-02 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
595
-100.0%
27,7716.523 USD |
595 -100.0% | 27,77 | 16.523 USD | |
| 2021-02-03 | 2021-02-02 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
700
-54.1%
26,8718.809 USD |
700 -54.1% | 26,87 | 18.809 USD | |
| 2021-02-03 | 2021-02-01 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
660
-100.0%
26,4317.444 USD |
660 -100.0% | 26,43 | 17.444 USD | |
| 2021-02-03 | 2021-02-01 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
800
-21.1%
24,3619.488 USD |
800 -21.1% | 24,36 | 19.488 USD | |
| 2021-01-21 | 2021-01-21 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
465
-100.0%
20,309.440 USD |
465 -100.0% | 20,30 | 9.440 USD | |
| 2021-01-21 | 2021-01-20 | GV Geplanter Verkauf |
Chief Medical Officer Führungsperson |
465
-100.0%
21,089.802 USD |
465 -100.0% | 21,08 | 9.802 USD |